Digital Patient Suite

31. IRT And eClinical Technology Considerations For Cell And Gene Therapy 8/20/2021

    Don't try to fit cell and gene therapy studies – or any kind of study – into pre-defined functionality. The Cenduit IRT and Quantum Interactive™ agile design platforms and reporting tools support clients’ most complex requirements.

32. Intelligent IRT Design Process For COVID-19 Trials Accelerates Digital Enablement At Sites 10/7/2021

    Find out what happened when study teams took on challenges pressing biopharmaceutical industry sponsors while working to digitally enable sites and speed up time to first-patient-in for COVID-19 therapeutic and vaccine trials.

33. Flexible IRT Platform Solution For National Lung Cancer Trial 2/24/2021

    Trial design for a medicine trial to investigate treatment for non-small cell lung cancer presents unique challenges. These include the need for an IRT platform that can support the rapid incorporation of amendments and account for multiple or potential arms requiring different lists of material types and dosages that could be prescribed to patients and supplied to sites. Cenduit’s highly-configurable, flexible technology platform was the solution.

34. Drug Accountability And Returns Management 8/20/2021

    This white paper illustrates how sponsors are using electronic solutions for Drug Accountability (DA), because they recognize the significant increase in efficiency and accuracy that these methods provide.

35. Cenduit Interactive Response Technology 2/24/2021

    Accelerate study start-up and amendments, simplify site and sponsor experience, reduce trial supply costs and improve study decision making while ensuring quality standards and patient safety during your trial with Cenduit Interactive Response Technology.

36. Five Frequently Asked Questions (And Answers) About eConsent During The COVID-19 Crisis 4/17/2020

    For the clinical research industry, COVID-19 poses immediate and long-term challenges that require sharing experiences with the industry now more than ever. This article provides the most frequently asked questions about eConsent technology.

     
37. Climbing The Ladder To Higher Electronic Consent Adoption 11/19/2021

    When it comes to gaining the benefits of eConsent in clinical trials, site adoption is the key. Explore the steps up the ladder of eConsent adoption to reach new heights with every study.

38. IQVIA Complete Consent 6/17/2021

    IQVIA Complete Consent combines a friendly, feature-rich technology platform that patients and sites are eager to use, with the powerful, scalable, operational infrastructure that sponsors need to make global implementations successful.

39. Navigating Patient Consent Scenarios In COVID-19 Trials 5/20/2020

    Many people have questions on the topic of remote consent in a hospital setting, particularly when the patient is quite ill and requires a legally acceptable representative (LAR) to consent on his or her behalf. This article shares insights gained through real-world implementations of remote consent.

40. Navigating The Use Of Controlled Substances In Clinical Trials Using IRT 8/20/2021

    Sponsor organizations that want to use controlled substances in clinical studies must manage the associated regulatory and logistical requirements. Read how this can be challenging for emerging biopharmas with smaller staffs and fewer resources.